Fenbendazole CAS 43210-67-9: Comprehensive Product Guide
Table of Contents
- 1. Product Overview & Specifications
- 2. Key Applications & Use Cases
- 3. Comparative Analysis with Alternatives
- 4. Industry Implementation Case Studies
- 5. Technical FAQs & Best Practices
- 6. Procurement Consultation
1. Product Overview & Specifications
| Parameter | Fenbendazole CAS 43210-67-9 |
|---|---|
| Molecular Formula | C15H13N3O2S |
| Molecular Weight | 299.35 g/mol |
| Appearance | White to off-white crystalline powder |
| Purity | ≥98.5% (HPLC) |
| Solubility | Insoluble in water, soluble in DMSO |
| Storage | 2-8°C in airtight container |
| Shelf Life | 36 months from production |
2. Key Applications & Use Cases
Veterinary Medicine
• Broad-spectrum anthelmintic for gastrointestinal parasites in livestock
• Effective against roundworms, tapeworms, and hookworms
• Standard treatment dose: 5 mg/kg body weight for 3 consecutive days
Research Applications
• Investigational cancer therapy adjunct in preclinical studies
• Mechanism: Tubulin polymerization inhibition (IC50 = 0.16 μM)
• Combination therapy with vitamin supplements for enhanced efficacy
3. Comparative Analysis with Alternatives
| Parameter | Fenbendazole | Albendazole | Mebendazole |
|---|---|---|---|
| Bioavailability | 5-10% | 20-30% | 2-10% |
| Half-life | 8-12 hrs | 8-12 hrs | 2.5-5.5 hrs |
| Spectrum | Nematodes, Cestodes | Nematodes, Trematodes | Nematodes |
| Cost Efficiency | High | Medium | Low |
4. Industry Implementation Case Studies
Case Study 1: Livestock Health Management
Client: AgriHealth Solutions Ltd. (Netherlands)
Challenge: 40% helminth infection rate in cattle herd
Solution: 10 mg/kg fenbendazole oral suspension for 5 days
Result: 92% parasite clearance rate, 15% weight gain improvement
Case Study 2: Oncology Research
Client: BioCancer Research Institute (USA)
Application: Combination therapy with metabolic inhibitors
Protocol: 50 mg/kg/day fenbendazole + 2 g/kg vitamin C
Outcome: 60% tumor growth inhibition in murine models
5. Technical FAQs & Best Practices
Q: What’s the stability in feed mixtures?
A: Maintains >95% potency for 6 months when stored below 25°C with desiccant
Q: Compatibility with other medications?
A: Avoid concurrent use with CYP450 inhibitors. Allow 72-hour interval between treatments
6. Procurement Consultation
Request custom formulation or bulk pricing:
• Email: info@vivalr.com
• Tel: (86) 15866781826
• Available formats: API powder, premix (5%, 10%, 20%), oral suspension
• MOQ: 1 kg (research grade), 25 kg (commercial grade)
Why Choose Us?
• ISO 9001-certified production facilities
• Batch-specific COA with HPLC/GC-MS analysis
• Global logistics support (DDP/DAP terms available)



评论
目前还没有评论。